Brief: Venmax Drugs And Pharmaceuticals Approves Change In Designation Of Venkat Rao Sadhanala From Whole-Time Director To Managing Director
31/08/2026 13:41
BRIEF-Venmax Drugs And Pharmaceuticals Approves Change In Designation Of Venkat Rao Sadhanala From Whole-Time Director To Managing Director Aug 31 (Reuters) - Venmax Drugs and Pharmaceuticals Ltd VENM.BO:
APPROVES CHANGE IN DESIGNATION OF VENKAT RAO SADHANALA FROM WHOLE-TIME DIRECTOR TO MANAGING DIRECTOR
Source text:
Further company coverage: VENM.BO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Venmax Drugs and Pharmaceuticals
See all newsBrief: Venmax Drugs And Pharmaceuticals Approves Change In Designation Of Venkat Rao Sadhanala From Whole-Time Director To Managing Director
Brief: Venmax Drugs To Consider Merger With Hatri Pharma
Brief: Venmax Drugs And Pharmaceuticals Says N. Krishnaiah Appointed As MD
Moody's affirms Societe Generale's A1 senior unsecured debt and deposit ratings; outlook remains stable